RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PISANO C
Collezione AOU San Luigi di Orbassano

Items : 16

Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma. in Journal of clinical medicine / J Clin Med. 2024 Jan 5;13(2):307. doi: 10.3390/jcm13020307.

2024
ASL Asti
AOU San Luigi di Orbassano

Di Stefano RF; Turco F; Delcuratolo MD; Pisano C; Saporita I; Calabrese M; Carfì FM; Buttigliero C; Tucci M; Samuelly A;

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.

2024
ASL Città di Torino
AO Cuneo
ASL Asti
ASL Cuneo 2
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Maio MD; Tucci M; Ortega C; Vellani G; Rossi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; Ruatta F; Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Cattrini C; Vignani F; Dionisio R; Icardi M; et alii...

Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience. in Biomedicines / Biomedicines. 2023 Jan 9;11(1):165. doi: 10.3390/biomedicines11010165.

2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Passiglia F; Scagliotti GV; D'Amiano C; Gianetta M; Di Maio M; Capelletto E; Bianco V; Napoli VM; Leone G; Turco F; Audisio A; Cecchi C; Delcuratolo MD; Cetoretta V; Parlagreco E; Pisano C; Garbo E; Ferrari G; Bironzo P; Persano I; Del Rio B; Cani M; Bertaglia V;

Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis. in Tumori / Tumori. 2023 Apr;109(2):233-243. doi: 10.1177/03008916221077144. Epub 2022 Mar 31.

2023
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Ungaro A; Audisio A; Audisio M; Parlagreco E; Samuelly A; Pisano C; Urban S; Angusti T; Parente A; Di Stefano RF; Tucci M; Turco F;

Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements. in Cancers / Cancers (Basel). 2022 Jan 30;14(3):718. doi: 10.3390/cancers14030718.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Reale ML; Novello S; Jacobs F; De Filippis M; Pisano C;

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. in Cells / Cells. 2022 Feb 25;11(5):803. doi: 10.3390/cells11050803.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Di Maio M; Turco F; Delcuratolo MD; Buttigliero C; Pisano C; Di Prima L; Audisio A; Ungaro A; Scagliotti GV;

How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC). in Cancer treatment reviews / Cancer Treat Rev. 2022 Feb;103:102335. doi: 10.1016/j.ctrv.2021.102335. Epub 2021 Dec 31.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Novello S; Ambrogio C; Swalduz A; Santamaria D; Pradines A; Planchard D; Nadal E; Mazieres J; Mezquita L; Pisano C; Tabbò F; Ortiz-Cuaran S;

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Buttigliero C; Tucci M; DI Maio M; Pisano C; Parente A; Bungaro M; Samuelly A; Turco F; Angusti T; DI Stefano RF;

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.

2022
ASL Asti
ASL Cuneo 2
ASL Torino 4
ASL Cuneo 1
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pisano C; Scagliotti GV; Di Maio M; Ortega C; Audisio M; Buttigliero C; Ungaro A; Turco F; Tucci M; Di Stefano RF; Audisio A; Delcuratolo MD;

Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.

2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Pisano C; Tucci M; Di Stefano RF; Audisio M; Bungaro M; Samuelly A; Turco F;

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Buttigliero C; Scagliotti GV; Di Maio M; Di Stefano RF; Turco F; Tucci M; Pisano C;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;

Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves. in JCO oncology practice / JCO Oncol Pract. 2021 Dec;17(12):e1887-e1894. doi: 10.1200/OP.21.00098. Epub 2021 Jul 6.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Passiglia F; Capelletto E; Boccuzzi A; Caramello V; Olmetto E; Persano I; De Filippis M; Pisano C; Bironzo P; Mariniello A; Di Maio M; Novello S;

Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.

2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU Alessandria

Scagliotti GV; Numico G; Guglielmini P; Lacidogna G; Turco F; Pisano C; Di Stefano RF; Vignani F; Sonetto C; Tucci M; Buttigliero C; Di Maio M;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24

2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Scagliotti GV; Di Maio M; Tucci M; Vignani F; Turco F; Tabbò F; Leone G; Buttigliero C; Di Stefano RF; Pisano C;

Prolonged Adrenal Insufficiency After the Discontinuation of Mitotane Therapy. in Endocrine, metabolic & immune disorders drug targets / Endocr Metab Immune Disord Drug Targets. 2020;20(3):485-487. doi: 10.2174/1871530319666190809144620.

2020
AOU San Luigi di Orbassano

Scagliotti GV; La Salvia A; Puglisi S; Pisano C; Reimondo G; Pia A; Muratori L; Sperone P;